2017 American Transplant Congress

Monday, May 1, 2017

3:06pm-3:18pm

Normothermic Donor Lung Preservation with Portable EVLP Significantly Reduces Ischemia/Reperfusion Injury in Lung Recipients by Promoting Cytokine Antagonists.

C. Falk,¹ B. Wiegmann,² C. Neudörfl,¹ C. Kühn,² I. Tudorache,² M. Wvsar,² A. Haverich,² G. Warnecke.²

Concurrent Session: Emerging Interventions in Ischemia Reperfusion Injury  •  E351

3:06pm-3:18pm

Post-Donation GFR Changes in Living Kidney Donors.

E. Poggio,¹ S. Arrigain,² J. Augustine,¹ S. Flechner,³ J. Schold.²

Concurrent Session: Living Kidney Donation: Post Donation Issues  •  E450b

3:06pm-3:18pm

Resumption of Standard Dose Immunosuppression Following Resolution of BK Viremia Does Not Lead to Viremia Recurrence.

K. Alquadan, A. Santos, M. Casey, T. Ozrazgat-Baslanti, S. Bozorgmehri, J. Gregg, K. Womer.

Concurrent Session: Kidney BK Virus  •  E451a

3:06pm-3:18pm

Risk of Ischemic Biliary Injury Is Not Associated with Prolonged Hepatic Artery Ischemic Times During Liver Transplantation.

E. Armenia,¹ N. Schomaker,¹ A. Kalra,¹ J. Gralla,¹ A. Truesdale,¹ S. Biggins,² T. Nydam,¹ J. Burton.¹

Concurrent Session: Liver Retransplantation and Other Complications  •  E353B

3:06pm-3:18pm

Safety and Activity of Anti-C1s Humanized Monoclonal Antibody TNT009 in Late Antibody-Mediated Kidney Allograft Rejection – Results of a First-in-Human Phase 1 Trial.

F. Eskandary,¹ B. Jilma,² J. Muehlbacher,³ M. Wahrmann,¹ H. Regele,⁴ N. Kozakowski,⁴ S. Panicker,⁵ J. Reeve,⁶ P. Halloran,⁶ J. Gilbert,⁵ G. Bohmig.¹

Concurrent Session: Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients  •  E354a

3:06pm-3:18pm

Validation of a Prediction Model for Cardiac Allograft Vasculopathy.

E. Kransdorf, T. Aintablian, M. Kittleson, J. Patel, J. Kobashigawa.

Concurrent Session: Heart Transplantation: Antibodies and Outcomes  •  E271b

3:18pm-3:30pm

Calibration of BK Virus Nucleic Acid Amplification Testing to the 1^st WHO International Standard for BK Virus.

S. Tan,¹ S. Milligan,² M. Sahoo,³ N. Taylor,² B. Pinsky.^1,2,3

Concurrent Session: Kidney BK Virus  •  E451a

3:18pm-3:30pm

Cardiovascular Events Are a Substantial and Increasing Cause of Graft Loss in Liver Transplant Recipients.

M. Sell, A. Mardis, I. Lee, B. O'Brien, C. Perez, A. Rogers, C. Mardis, N. Patel, J. Fleming, H. Meadows, N. Pilch, K. Chavin, D. Taber.

Concurrent Session: Liver Retransplantation and Other Complications  •  E353B

3:18pm-3:30pm

Differential Expression of Long Noncoding RNAs During Cardiac Allograft Rejection.

G. Gu, H. Hang, T. Lu, Q. Xia.

Concurrent Session: Mechanisms of Allograft Rejection  •  E352

3:18pm-3:30pm

Experience with Obinutuzumab (Type II Anti-CD20) in Kidney Transplant Patients with Donor Specific Antibody (DSA+) Antibody Mediated Rejection.

J. Choi, A. Vo, E. Huang, S. Louie, A. Kang, A. Peng, R. Najjar, S. Jordan.

Concurrent Session: Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients  •  E354a